Based on this, n = 34 mice per group was considered appropriate to detect treatment-associated trends while complying with ethical principles for animal research
Retatrutide, a triple agonist targeting gastric inhibitory polypeptide (GIP), GLP-1, and glucagon receptors, has achieved highly promising outcomes in its phase 2 trial [22], with weight loss up to 24%
Tirzepatide SURMOUNT trials: raising the bar Then came the SURMOUNT trials
The association of genetically predicted l-carnitine with CAD in men not in women is possibly due to a smaller number of CAD cases in women therefore a lower power (as shown in Additional file 1: Table S6)
Hemolysis is a parameter of fundamental importance in hemocompatibility testing [448, 449]
However, muscle loss often results from rapid weight loss, regardless of the method